Schedule a Demo

MIM Software

Prostate Cancer and the MRI Directed Pathway

Urology and Radiology in Synergy

Urologists Need High-Quality Radiology Reports

The Diagnostic Pathway for Prostate Cancer Has Evolved

Worldwide urologic guidelines now point to mpMRI prior to every biopsy. This means Radiology's interpretation of mpMRI is critical to the prostate cancer pathway.

But, today’s reporting results in missed biopsy targets.

Existing nomenclature carries different meanings between Radiology and Urology departments. For example, right-mid medial on a Radiologist's MRI may be dissimilar to right-mid medial on a Urologist's ultrasound image during biopsy. Tools that ensure accurate communication between Radiology and Urology are critical to enhancing patient outcomes.

1 in 6 lesions are subject to misinterpretation.¹

17% of lesions are localized in different sectors by Radiology and Urology.¹

You are not wrong.

Radiology and Urology are speaking two different languages.

As a result of differences in patient positioning during MRI acquisition and biopsy, one in six lesions are reported in a different sector than they appear during US-guided biopsy.¹ In fact, the average orientation difference between MRI and ultrasound biopsy is 12 degrees.¹

Additional Resources

Download additional information and sign up for our webinar

Prostate MR Pathway Product Sheet

Do more together with Predictive Fusion®

Do more with MRI.

MIM Symphony^® allows Urologists and Radiologists to speak the same language. Radiologic findings are efficiently translated for targeted biopsies and an MRI empowered prostate care pathway.

Reference:

1 J Piper, F Giganti, D Mirando, K Krawiec, AS Nelson, C Allen, MIM Software Inc, University College London Hospital; Evaluation of the impact of orientation differences between mpMRI and US in biopsy. Study presented at the European Society of Urogenital Radiology Association, Barcelona, SP

Request a Demo

MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions for PC and Mac^® workstations, as well as mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.

Copyright © 2024 MIM Software Inc. All Rights Reserved.